— About Eligo — Eligo Bioscience, backed by top-tier investors from Silicon Valley and Europe, is pioneering next-generation microbiome therapeutics. Co-founded by MIT and Rockefeller University scientists, Eligo is headquartered in Paris, France. Our mission is to
// Your mission Eligo is building a pioneering platform technology that enables us to engineer phage-derived particles (Eligobiotics) to package and deliver modular therapeutic DNA payloads to genetically (re)program a wide range of bacterial species in-situ.